Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02286921
Title Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

prostate adenocarcinoma

Therapies

Enzalutamide

Testosterone

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Unversity of Alabama Birmingham Alabama 35294 United States Details
City of Hope Duarte California 91010 United States Details
University of Colorado Cancer Center Aurora Colorado 80045 United States Details
Sibley Memorial Hospital Washington District of Columbia 20016 United States Details
Piedmont Cancer Institute Atlanta Georgia 30318 United States Details
University of Chicago Chicago Illinois 60637 United States Details
University of Kansas Cancer Center Kansas City Kansas 66160 United States Details
Tulane University Medical Center New Orleans Louisiana 70112 United States Details
University of Maryland Baltimore Maryland 21201 United States Details
SKCCC at Johns Hopkins Baltimore Maryland 21205 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
Neraska Cancer Specialists Omaha Nebraska 68130 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08901 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Allegheny Health Network Pittsburgh Pennsylvania 15212 United States Details
Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
University of Washing Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field